Inflammatory Disorders - Part B: Volume 120

ISBN-13: 9780128213223 / Angielski / Twarda / 2020 / 152 str.

Rossen Donev

Spis treści

1. Proteins in monogenic autoinflammatory disorders Riccardo Papa 2. Virulence factors and their roles in periodontal disease pathogenesis Shuang Liang 3. Role of Heat shock proteins in Inflammatory disorder Rheumatoid Arthritis Ashok K. Munjal 4. Novel targeted therapies for Crohn's disease: Recent progress and future perspectives Anupam Bishayee 5. Dietary plant flavonoids in prevention of obesity and diabetes Biswanath Dinda Sr. 6. Small RNAs in allergic diseases Jorg Tost 7. Inflammation and inflammasome during ageing and age-related diseases Mario D. Cordero 8. Immunotherapies: Successes and failures Joanna Giles 9. A comprehensive in silico screening, molecular dynamics studies of SNPs in Sjogren-Larsson Syndrome associated with ALDH3A2 gene George Priya Doss C 10. A computational approach to decipher the structural and functional impact of missense mutations of MEFV protein causing Familial Mediterranean fever George Priya Doss C

O autorze

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.